This study will determine the safety and pharmacokinetics of AMG 706 in subjects with advanced solid tumors.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
71
Anti-angiogenesis
Anti-angiogenesis
Dose limiting toxicity
Time frame: Cycle 1
Dose selection
Time frame: Study completion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.